Clinical Trial Update: ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®) [Phase 2]

View source ↗

Summary

Phase 2 trial updating consolidation strategies in previously untreated follicular lymphoma comparing 90Y-ibritumomab tiuxetan (Zevalin) consolidation to rituxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Lymphoma | Phase 2 | Status: COMPLETED